(a)
In general— Not later than 180 days after the date of the enactment of this Act, the Secretary of Health and Human Services shall issue guidelines for prescribing an opioid overdose reversal drug.
(b)
Contents— In issuing guidelines under subsection (a), the Secretary shall address the following:
(1)
Co-prescribing an opioid overdose reversal drug in conjunction with any prescribed opioid.
(3)
Prescribing an opioid overdose reversal drug to an individual other than a patient.
(5)
Other distribution, education, and safety measures as determined necessary.